• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

QleanAir signs approximately $127,000 USD design agreement with leading U.S. West Coast integrated health system, marking first cleanroom project with customer

QAIRPressemeddelelse05.08.2026, 10.30
Discuss

QleanAir AB (publ), a leading provider of premium cleanroom and air quality solutions, has signed an agreement with a major not-for-profit integrated delivery network on the U.S. West Coast. The healthcare organization operates an extensive network of hospitals, ambulatory care centers, physician practices, and specialty facilities, serving millions of patients annually.

The agreement covers the design of a USP 797/800 compliant cleanroom for pharmacy compounding within a hospital facility. The project marks the customer’s first engagement with QleanAir, and the design is expected to be completed by the end of the third quarter of 2026.

"This agreement represents another important step in QleanAir's continued expansion within the U.S. healthcare market," said Amanda Myers, Chief Commercial Officer, QleanAir Scandinavia Inc. "Leading healthcare organizations are increasingly recognizing the value of engaging experienced cleanroom specialists early in the planning process to optimize workflows, reduce project risk, and deliver long-term value."

The design agreement reflects the growing demand for strategic cleanroom planning that balances compliance, operational efficiency, and speed to implementation. By partnering with healthcare providers during the earliest stages of project development, QleanAir helps establish a strong foundation for successful project execution.

"We appreciate the trust our customer has placed in our team and look forward to delivering a design that supports their mission of providing exceptional patient care," added Zachary Douglas, President, QleanAir Scandinavia Inc.

For more information, please contact:


Sebastian Lindström, CEO
sebastian.lindstrom@qleanair.com
+46 703 08 94 51

Fredrik Sandelin, CFO
fredrik.sandelin@qleanair.com
+46 722 09 61 67

About QleanAir


QleanAir is a niche premium provider of clean indoor environment solutions. The company’s business model is based on rental contracts for modular solutions with a full-service offer. QleanAir’s solutions are developed using filter technology that traps, filters and recycles indoor air. The company’s main markets are EMEA, APAC and the Americas. QleanAir’s head office is located in Solna, Sweden, and the share is traded on Nasdaq First North Premier Growth Market, ticker QAIR. FNCA Sweden is Certified Advisor. For more information go to qleanair.com.

Attachments


QleanAir signs approximately $127,000 USD design agreement with leading U.S. West Coast integrated health system, marking first cleanroom project with customer